Riba Jordi, de Romani Santiago Escriva, Masia Jaume
Department of Plastic Surgery, Hospital de la Santa Creu i Sant Pau, Universitat Autonoma de Barcelona, Sant Antoni Maria Claret 167, Barcelona 08025, Spain.
Department of Medical Oncology, Hospital Universitario Vall d'Hebron, Universitat Autonoma de Barcelona, Passeig de la Vall d'Hebron, 119-129, Barcelona 08035, Spain.
Clin Plast Surg. 2018 Jan;45(1):25-31. doi: 10.1016/j.cps.2017.08.014.
This article aims to determine the impact of neoadjuvant chemotherapy on immediate breast reconstruction by assessing their compatibility for oncological safety and the incidence and management of postoperative complications. A review of scientific publications published between 2009 and 2017 was undertaken. The relationship between neoadjuvant chemotherapy and immediate breast reconstruction was analyzed to compile and assess the potential interaction between the procedures. The search was limited to English language publications, but there were no limiting factors at the level of study typology. Full-text articles, including the references leading to other relevant studies, were evaluated.
本文旨在通过评估新辅助化疗与即刻乳房重建在肿瘤学安全性方面的兼容性以及术后并发症的发生率和处理情况，来确定新辅助化疗对即刻乳房重建的影响。我们对2009年至2017年间发表的科学文献进行了综述。分析了新辅助化疗与即刻乳房重建之间的关系，以汇总和评估这两种手术之间的潜在相互作用。检索仅限于英文出版物，但在研究类型层面没有限制因素。对全文文章进行了评估，包括指向其他相关研究的参考文献。
